Hypothalamic glucose sensing and glycaemic disease

Current Diabetes Reviews

Volumn 7, Issue 2, 2011, Pages 84-98

  Osundiji, Mayowa A ^a,b   Evans, Mark L ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Brain; Glucose; Glycaemia hypothalamus; Neurones; Sensors

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOKINASE; GLUCOSE; GLUCOSE TRANSPORTER 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; POTASSIUM CHANNEL; REACTIVE OXYGEN METABOLITE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; GLUCOSE BLOOD LEVEL; INSULIN;

ASTROCYTE; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; HYPOGLYCEMIA; HYPOTHALAMUS; HYPOTHALAMUS GLUCOSE SENSOR; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NERVE CELL; NERVOUS SYSTEM PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; ANIMAL; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HYPERGLYCEMIA; LIVER; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION (PROCESS); SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ASTROCYTES; BLOOD GLUCOSE; GLUCOKINASE; GLUCOSE; HOMEOSTASIS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOTHALAMUS; INSULIN; INSULIN-SECRETING CELLS; KATP CHANNELS; LIVER; MICE; MICE, TRANSGENIC; NEURONS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 79953017084     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339911794940701     Document Type: Review

References (207)

1. Hevener A, Bergman R, Donovan C. Novel glucosensor for hypoglycaemic detection localized to the portal vein. Diabetes 1997; 46: 1521-5.
2. Fujita S, Donovan CM. Celiac-superior mesenteric ganglionectomy, but not vagotomy, suppresses the sympathoadrenal response to insulin-induced hypoglycaemia. Diabetes 2005; 54: 3258-64.
3. Pardal R, Lopez-Barneo J. Low glucose-sensing cells in the carotid body. Nat Neurosci 2002; 5: 197-8.
4. Prentki M, Tornheim K, Corkey B. Signal transduction mechanisms in nutrient-induced insulin secretion. Diabetologia 1997; 40 (Suppl. 2): S32-41.
5. Reimann F, Gribble F. Glucose sensing in GLP-1 secreting cells. Diabetes 2002; 5: 2757-63.
6. Gribble F, Williams L, Simpson A, Reimann F. A novel glucosesensing mechanism contributing to glucagon-like peptide-1 secretion from the glutag cell line. Diabetes 2003; 52: 1147-54.
7. Oomura Y, Kimura K, Ooyama H, Maeo T, Iki M, Kuniyoshi N. Reciprocal activities of the ventromedial and lateral hypothalamic area of cats. Science 1964; 143: 484-5.
8. Oomura Y, Ooyama H, Sugimori M, Nakamura T, Yamada Y. Glucose inhibition of the glucose-sensitive neurone in the rat lateral hypothalamus. Nature 1974; 247: 284-6.
9. Anand B, Chhina G, Sharma K, Dua S, Singh B. Activity of single neurones in the hypothalamus feeding centers: effect of glucose. Am J Physiol 1964; 207: 1146-54.
10. Grupe A, Hultgren B, Ryan A, Ma YH, Bauer M, Stewart TA. Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis. Cell 1995; 83: 69-78.
11. Postic C, Shiota M, Niswender KD, et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem 1999; 274(1): 305-15.
12. Yang X-J, Mastaitis J, Mizuno T, Mobbs CV. Glucokinase regulates reproductive function, glucocorticoid secretion, food intake, and hypothalamic gene expression. Endocrinology 2007; 148: 1928-32.
13. Levin BE, Becker TC, Eiki J, Zhang BB, Dunn-Meynell AA. Ventromedial hypothalamic glucokinase is an important mediator of the counterregulatory response to insulin-induced hypoglycaemia. Diabetes 2008; 57: 1371-9.
14. Kang L, Dunn-Meynell A, Routh V, et al. Glucokinase is a critical regulator of ventromedial hypothalamic neuronal glucosensing. Diabetes 2006; 55(2): 412-20.
15. Guillam M-T, Hümmler E, Schaerer E, et al. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking GLUT2. Nat Genet 1997; 17: 327-30.
16. Wan HZ, Hulsey MG, Martin RJ. Intracerebroventricular administration of antisense oligodeoxynucleotide against GLUT2 glucose transporter mRNA reduces food intake, body weight change and glucoprivic feeding response in rats. J Nutr 1998; 128(2): 287-91.
17. Bady I, Marty N, Dallaporta M, et al. Evidence from Glut2-null mice that glucose is a critical physiological regulator of feeding. Diabetes 2006; 55: 988-95.
18. Miki T, Nagashima K, Tashiro F, et al. Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. Proc Natl Acad Sci USA 1998; 95: 10402-6.
19. Seghers V, Nakazaki M, DeMayo F, Aguilar-Bryan L, Bryan J. Sur1 knockout mice. A model for K(ATP) channel-independent regulation of insulin secretion. J. Biol Chem 2000; 275: 9270-7.
20. Parton LE, Ye CP, Coppari R, et al. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 2007; 449: 228-32.
21. Velho G, Blanche H, Vaxillaire M, et al. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia 1997; 40: 217-24.
22. Vionnet N, Stoffel M, Takeda J, et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 1992; 356: 721-2.
23. Froguel P, Vaxillaire M, Sun F, et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 1992; 356: 162-4.
24. Froguel P, Zouali H, Vionnet N, et al. Familial hyperglycaemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 1993; 328: 697-702.
25. Glaser B, Kesavan P, Heyman M, et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 1998; 338: 226-30.
26. Dunne MJ, Kane C, Shepherd RM, et al. Familial persistent hyperinsulinemic hypoglycaemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med 1997; 336: 703-6.
27. Thomas PM, Cote GJ, Wohllk N, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycaemia of infancy. Science 1995; 268: 426-9.
28. Sokoloff L, Reivich M, Kennedy C, et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977; 23: 897-916.
29. Adachi A, Shimizu N, Oomura Y, Kobashi M. Convergence of heptoportal glucose-sensitive afferent signals to glucose-sensitive units within the nucleus of the solitary tract. Neurosci Lett 1984; 46: 215-8.
30. Mizuno Y, Oomura Y. Glucose responding neurones in the nucleus tractus solitarius of the rat, in vitro study. Brain Res 1984; 307: 109-16.
31. Kow LM, Pfaff D. Actions of feeding-relevant agents on hypothalamic glucose-responsive neurones in vitro. Brain Res Bull 1985; 15: 509-13.
32. Silver I, Erecinska M. Glucose-induced intracellular ion changes in sugar-sensitive hypothalamic neurones. J Neurophysiol 1998; 79: 1733-45.
33. Shoji S. Glucose regulation of synaptic transmission in the dorsolateral septal nucleus of the rat. Synapse 1992; 12: 322-32.
34. Lee K, Dixon AK, Freeman TC, Richardson PJ. Identification of an ATP-sensitive potassium channel current in rat striatal cholinergic interneurones. J Physiol 1998; 510: 441-53.
35. Lee K, Dixon AK, Rowe IC, Ashford ML, Richardson PJ. The high-affinity sulphonylurea receptor regulates KATP channels in nerve terminals of the rat motor cortex. J Neurochem 1996; 66: 2562-71.
36. Levin B, Dunn-Meynell A, Routh V. Brain glucose sensing and body energy homeostasis: role in obesity and diabetes. Am J Physiol 1999; 276 (5 Pt. 2): R 1223-31.
37. Dunn-Meynell A, Routh V, Kang L, Gaspers L, Levin B. Glucokinase is the likely mediator of glucosensing in both glucoseexcited and glucose-inhibited central neurones. Diabetes 2002; 51: 2056-65.
38. Kang L, Routh V, Kuzhikandathil E, Gaspers L, Levin B. Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurones. Diabetes 2004; 53: 549-59.
39. Fioramonti X, Contie S, Song Z, Routh VH, Lorsignol A, Penicaud L. Characterization of glucosensing neuron subpopulations in the arcuate nucleus: integration in neuropeptide Y and pro-opio melanocortin networks. Diabetes 2007; 56: 1219-27.
40. Song Z, Routh VH. Differential effects of glucose and lactate on glucosensing neurones in the ventromedial hypothalamic nucleus. Diabetes 2005; 54: 15-22.
41. Elsas LJ, Longo N. Glucose transporters. Annu Rev Med 1992; 43: 377-93.
42. Glick Z, Mayer J. Hyperphagia caused by cerebral ventricular infusion of phloridzin. Nature 1968; 219: 1374.
43. Tsujii S and Bray GA. Effects of glucose, 2-deoxyglucose, phlorizin, and insulin on food intake of lean and fatty rats. Am J Physiol 1990; 258: E476-81.
44. Yang XJ, Kow LM, Funabashi T, Mobbs CV. Hypothalamic glucose sensor, similarities to and differences from pancreatic α-cell mechanisms. Diabetes 1999; 48: 1763-72.
45. Diez-Sampedro A, Hirayama BA, Osswald C, et al. A glucose sensor hiding in a family of transporters. Proc Natl Acad Sci USA 2003; 100:11753-8.
46. Holsbeeks I, Lagatie O, Van Nuland A, Van de Velde S, Thevelein JM. The eukaryotic plasma membrane as a nutrient-sensing device. Trends Biochem Sci 2004; 29: 556-64.
47. Stanford I, Lacey M. Regulation of a potassium conductance in rat midbrain dopamine neurones by intracellular adenosine triphosphate (ATP) and the sulfonylureas tolbutamide and glibenclamide. J Neurosci 1995; 15: 4651-7.
48. Ashford M, Boden P, Treherne J. Glucose-induced excitation of hypothalamic neurones is mediated by ATP-sensitive K+ channels. Pflugers Arch 1990; 415: 479-83
49. McCrimmon RJ, Evans ML, Fan X, et al. Activation of ATPsensitive K+ channels in the ventromedial hypothalamus amplifies counterregulatory hormone responses to hypoglycaemia in normal and recurrently hypoglycaemic rats. Diabetes 2005; 54: 3169-74.
50. Pocai A, Lam T, Gutierrez-Juarez R, et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 2005; 434: 1026-31.
51. Evans ML, McCrimmon RJ, Flanagan DE, et al. Hypothalamic ATP-sensitive K + channels play a key role in sensing hypoglycaemia and triggering counterregulatory epinephrine and glucagon responses. Diabetes 2004; 53: 2542-51.
52. Roncero I, Alvarez E, Chowen J, et al. Expression of glucose transporter isoform GLUT-2 and glucokinase genes in human brain. J Neurochem 2004; 88(5): 1203-10.
53. Matschinsky F, Glaser B, Magnuson M. Pancreatic ß-cell glucokinase: closing the gap between theoretical concepts and experimental realities. Diabetes 1998; 47: 307-15.
54. Newgard C, McGarry J. Metabolic coupling factors in pancreatic ßcell signal transduction. Annu Rev Biochem 1995; 64: 689-719.
55. Henquin J, Gembal M, Detimary P, Gao Z, Warnotte C, Gilon P. Multisite control of insulin release by glucose. Diabetes Metab 1994; 20: 132-7.
56. Schuit F, Moens K, Heimberg H, Pipeleers D. Cellular origin of hexokinase in pancreatic islets. J Biol Chem 1999; 274: 32803-9.
57. Detimary P, Dejonghe S, Ling Z, Pipeleers D, Schuit F, Henquin J. The changes in adenine nucleotides measured in glucose-stimulated rodent islets occur in α-cells but not in α-cells, and are also observed in human islets. J Biol Chem 1998; 273: 33905-8.
58. Thorens B, Sarkar H, Kaback H, Lodish H. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and ß-pancreatic islet cells. Cell 1988; 55: 281-90.
59. Matschinsky F, Magnuson M, Zelent D, et al. The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes 2006; 55: 1-12.
60. German M. Glucose sensing in pancreatic islet beta cells: the key role of glucokinase and the glycolytic intermediates. Proc Natl Acad Sci USA 1993; 90: 1781-5.
61. Ghosh A, Ronner P, Cheong E, Khalid P, Matschinsky F. The role of ATP and free ADP in metabolic coupling during fuel-stimulated insulin release from islet beta-cells in the isolated perfused rat pancreas. J Biol Chem 1991; 266: 22887-92.
62. MacDonald M. Elusive proximal signals of beta-cells for insulin secretion. Diabetes 1990; 39: 1461-6.
63. Dean P, Mathews E, Sakamoto Y. Pancreatic islet cells: effects of monsaccharides, glycolytic intermediates and metabolic inhibitors on membrane potential and electrical activity. J Physiol 1975; 246: 459-78.
64. Ganong WF. Circumventricular organs: definition and role in the regulation of endocrine and autonomic function. Clin Exp Pharmacol Physiol 2000; 27: 422-7.
65. Elmquist JK, Elias CF, Saper CB. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 1999; 22: 221-32.
66. Fioramonti X, Lorsignol A, Taupignon A, Penicaud L. A new ATP-sensitive K+ channel-independent mechanism is involved in glucose-excited neurones of mouse arcuate nucleus. Diabetes 2004; 53: 2767-75.
67. Seino S, Miki T. Physiological and pathophysiological roles of ATP-sensitive K+ channels. Prog Biophys Mol Biol 2003; 81: 133-76.
68. Cook DL, Satin LS, Ashford ML, Hales CN. ATP-sensitive potassium channels in pancreatic ß-cells: spare-channel hypothesis. Diabetes 1988; 37: 495-8.
69. Dunn-Meynell AA, Rawson NE, Levin BE. Distribution and phenotype of neurones containing the ATP-sensitive K+ channel in rat brain. Brain Res 1998; 814: 41-54.
70. Spanswick D, Smith MA, Groppi VE, Logan SD, Ashford ML. Leptin inhibits hypothalamic neurones by activation of ATPsensitive potassium channels. Nature 1997; 390: 521-5.
71. Miki T, Liss B, Minami K, et al. ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat Neurosci 2001; 4: 507-12.
72. Christesen HB, Jacobsen BB, Odili S, et al. The second activating glucokinase mutation (A456V): Implications for glucose homeostasis and diabetes therapy. Diabetes 2002; 51: 1240-6.
73. Clement K, Pueyo M, Vaxillaire M, et al. Assessment of insulin sensitivity in glucokinase-deficient subjects. Diabetologia 1996; 39(1): 82-90.
74. Velho G, Petersen K, Perseghin G, et al. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest 1996; 98: 1755-61.
75. Gabriely I, Hawkins M, Vilcu C, Rossetti L, Shamoon H. Fructose amplifies counterregulatory responses to hypoglycaemia in humans. Diabetes 2002; 51: 893-900.
76. Gabriely I, Shamoon H. Fructose normalizes specific counterregulatory responses to hypoglycaemia in patients with T1DM. Diabetes 2005; 54: 609-16.
77. Jetton T, Liang Y, Pettepher C, et al. Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. J Biol Chem 1994; 269: 3641-54.
78. Maekawa F, Toyoda Y, Torii N, et al. Localization of glucokinaselike immunoreactivity in the rat lower brain stem: for possible location of brain glucose-sensing mechanisms. Endocrinology 2000; 141: 375-84.
79. Roncero I, Alvarez E, Vázquez P, Blázquez E. Functional glucokinase isoforms are expressed in rat brain. J Neurochem 2000; 74(5): 1848-57.
80. Sutherland VL, McReynolds M, Tompkins LS, Brooks HL, Lynch RM. Developmental expression of glucokinase in rat hypothalamus. Brain Res Dev Brain Res 2005; 154(2): 255-8.
81. Wang R, Liu X, Dunn-Meynell A, Levin B, Routh V. The regulation of glucose-excited (GE) neurones in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 2004; 53: 1959-65.
82. Yang X, Kow L, Pfaff D, Mobbs C. Metabolic pathways that mediate inhibition of hypothalamic neurones by glucose. Diabetes 2004; 53: 67-73.
83. Moriyama R, Tsukamura H, Kinoshita M, Okazaki H, Kato Y, Maeda K. In vitro increase in intracellular calcium concentrations induced by low or high extracellular glucose levels in ependymocytes and serotonergic neurones of the rat lower brainstem. Endocrinology 2004; 145: 2507-15.
84. Heimberg H, De Vos A, Moens K, et al. The glucose sensor protein glucokinase is expressed in glucagon-producing alpha-cells. Proc Natl Acad Sci USA 1996; 93: 7036-41.
85. Sanders N, Dunn-Meynell A, Levin B. Third ventricular alloxan reversibly impairs glucose counterregulatory responses. Diabetes 2004; 53: 1230-6.
86. Kang L, Sanders NM, Dunn-Meynell AA, et al. Prior hypoglycaemia enhances glucose responsiveness in some ventromedial hypothalamic glucosensing neurons. Am J Physiol Regul Integr Comp Physiol 2008; 294(3): R784-92.
87. Osundiji MA, Zhou L, Shaw J, et al. Brain glucosamine boosts protective glucoprivic feeding. Endocrinology 2010; 151(4): 1499-508.
88. Dunn-Meynell AA, Sanders NM, Compton D, et al. Relationship among brain and blood glucose levels and spontaneous and glucoprivic feeding. J Neurosci 2009; 29(21): 7015-22.
89. Hardie DG, Carling D, Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?. Annu Rev Biochem 1998; 67:821-55.
90. Sutherland CM, Hawley SA, McCartney RR, et al. Elm1p is one of three upstream kinases for the Saccharomyces cerevisiae SNF1 complex. Curr Biol 2003; 13: 1299-305.
91. Hawley SA, Selbert MA, Goldstein EG, Edelman AM, Carling D, Hardie DG. 5'-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J Biol Chem 1995; 270: 27186-91.
92. Jenne DE, Reimann H, Nezu J, et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998; 18: 38-43.
93. Lizcano JM, Goransson O, Toth R, et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 2004; 23: 833-43.
94. Hardie DG, Sakamoto K. AMPK: A Key Sensor of Fuel and Energy Status in Skeletal Muscle. Physiology (Bethesda) 2006; 21: 48-60.
95. Minokoshi Y, Alquier T, Furukawa N, et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004; 428: 569-74.
96. Han SM, Namkoong C, Jang PG, et al. Hypothalamic AMPactivated protein kinase mediates counter-regulatory responses to hypoglycaemia in rats. Diabetologia 2005; 48(10): 2170-8.
97. McCrimmon RJ, Fan X, Ding Y, Zhu W, Jacob RJ, Sherwin RS. Potential role for AMP-activated protein kinase in hypoglycaemia sensing in the ventromedial hypothalamus. Diabetes 2004; 53: 1953-8.
98. McCrimmon RJ, Fan X, Cheng H, et al. Activation of AMPactivated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation. Diabetes 2006; 55: 1755-60.
99. McCrimmon RJ, Shaw M, Fan X, et al. Key Role for AMPactivated protein kinase in the ventromedial hypothalamus in regulating counterregulatory hormone responses to acute hypoglycaemia. Diabetes 2008; 57: 444-50.
100. Alquier T, Kawashima J, Tsuji Y, Kahn BB. Role of hypothalamic adenosine 5'-monophosphate-activated protein kinase in the impaired counterregulatory response induced by repetitive neuroglucopaenia. Endocrinology 2007; 148(3): 1367-75.
101. Turrens JF. Superoxide production by the mitochondrial respiratory chain. Biosci Rep 1997; 17: 3-8.
102. Yamagishi SI, Edelstein D, Du XL, Brownlee M. Hyperglycaemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes 2001; 50: 1491-4.
103. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol 1998; 10(2): 248-53.
104. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95.
105. Nemoto S, Takeda K, Yu ZX, Ferrans VJ, Finkel T. Role for mitochondrial oxidants as regulators of cellular metabolism. Mol Cell Biol 2000; 20: 7311-8.
106. Casteilla L, Rigoulet M, Penicaud L. Mitochondrial ROS metabolism: modulation by uncoupling proteins. IUBMB Life 2001; 52: 181-8.
107. Leloup C, Magnan C, Benani A, et al. Mitochondrial reactive oxygen species are required for hypothalamic glucose sensing. Diabetes 2006; 55: 2084-90.
108. Benani A, Troy S, Carmona MC, et al. Role for mitochondrial reactive oxygen species in brain lipid sensing. Diabetes 2007; 56: 152-60.
109. Ainscow EK, Mirshamsi S, Tang T, Ashford ML, Rutter GA. Dynamic imaging of free cytosolic ATP concentration during fuel sensing by rat hypothalamic neurones: evidence for ATPindependent control of ATP-sensitive K+ channels. J Physiol 2002; 544: 429-45.
110. Guillod-Maximin E, Lorsignol A, Alquier T, Penicaud L. Acute intracarotid glucose injection towards the brain induces specific cfos activation in hypothalamic nuclei: involvement of astrocytes in cerebral glucose-sensing in rats. J Neuroendocrinol 2004; 16: 464-71.
111. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. Effect of hyperketonemia and hyperlacticacidemia on symptoms, cognitive dysfunction, and counterregulatory hormone responses during hypoglycemia in normal humans. Diabetes 1994; 43: 1311-7.
112. Maran A, Cranston I, Lomas J, Macdonald I, Amiel SA. Protection by lactate of cerebral function during hypoglycemia. Lancet 1994; 343: 16-20.
113. Borg MA, Tamborlane WV, Shulman GI, Sherwin RS. Local lactate perfusion of the ventromedial hypothalamus suppresses hypoglycemic counterregulation. Diabetes 2003; 52(3): 663-6.
114. Lam TK, Gutierrez-Juarez R, Pocai A, Rossetti L. Regulation of blood glucose by hypothalamic pyruvate metabolism. Science 2005; 309(5736): 943-7.
115. Burdakov D, Jensen LT, Alexopoulos H, Williams RH, Fearon IM, O'Kelly I, et al. Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose. Neuron 2006; 50: 711-22.
116. Mountjoy PD, Bailey SJ, Rutter GA. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity. Diabetologia 2007; 50: 168-77.
117. Song Z, Levin BE, McArdle JJ, Bakhos N, Routh VH. Convergence of pre- and postsynaptic influences on glucosensing neurons in the ventromedial hypothalamic nucleus. Diabetes 2001; 50: 2673-81.
118. Ibrahim N, Bosch MA, Smart JL, et al. Hypothalamic proopiomelanocortin neurons are glucose responsive and express KATP channels. Endocrinology 2003; 144: 1331-40.
119. Claret M, Smith MA, Batterham RL, et al. AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. J Clin Invest 2007; 117(8): 2325-36.
120. Burdakov D, Gerasimenko O, Verkhratsky A. Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ. J Neurosci 2005; 25: 2429-33.
121. Howard AD, Wang R, Pong SS, et al. Identification of receptors for neuromedin U and its role in feeding. Nature 2000; 406: 70-4.
122. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G proteincoupled receptors that regulate feeding behavior. Cell 1998; 92: 573-85.
123. Edwards C, Abusnana S, Sunter D, Murphy K, Ghatei M, Bloom S. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J Endocrinol 1999; 160: R7-12.
124. Muroya S, Yada T, Shioda S, Takigawa M. Glucose-sensitive neurons in the rat arcuate nucleus contain neuropeptide Y. Neurosci Lett 1999; 264: 113-6.
125. Yamanaka A, Beuckmann CT, Willie JT, et al. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003; 38: 701-13.
126. Liu XH, Morris R, Spiller D, White M, Williams G. Orexin A preferentially excites glucose-sensitive neurons in the lateral hypothalamus of the rat in vitro. Diabetes 2001; 50: 2431-7.
127. Routh VH, McArdle JJ, Sanders NM, Song Z, Wang R. Physiological roles for glucose sensors. In: Glucose sensing neurones. Springer-Verlag, Berlin 2007; p. 219.
128. Lam T, Pocai A, Gutierrez-Juarez R, et al. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med 2005; 11: 320-7.
129. Pocai A, Obici S, Schwartz G, Rossetti L. A brain-liver circuit regulates glucose homeostasis. Cell Metab 2005; 1: 53-60.
130. Obici S, Feng Z, Arduini A, Conti R, Rossetti L. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 2003; 9: 756-61.
131. Obici S, Feng Z, Morgan K, Stein D, Karkanias G, Rossetti L. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 2002; 51: 271-5.
132. Obici S, Zhang B, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002; 8: 1376-82.
133. Cruciani-Guglielmacci C, Hervalet A, Douared L, et al. Beta oxidation in the brain is required for the effects of non-esterified fatty acids on glucose-induced insulin secretion in rats. Diabetologia 2004; 47: 2032-8.
134. Clément L, Cruciani-Guglielmacci C, Magnan C, et al. Intracerebroventricular infusion of a triglyceride emulsion leads to both altered insulin secretion and hepatic glucose production in rats. Pflugers Arch 2002; 445(3): 375-80.
135. Atef N, Ktorza A, Pénicaud L. CNS involvement in the glucoseinduced increase of islet blood flow in obese Zucker rats. Int J Obes Relat Metab Disord 1995; 19: 103-7.
136. Hepburn DA. Symptoms of hypoglycemia. In Frier BM, Fisher BM Eds. Hypoglycemia and Diabetes: Clinical and Physiological Aspects 1993; pp. 93-103.
137. Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH. Lack of glucagon response to hypoglycaemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 1973; 182: 171-3.
138. Clarke W, Cox D, Gonder-Frederick L, Julian D, Schludt D, Polonsky W. Reduced awareness of hypoglycaemia in adults with IDDM: A prospective study of hypoglycaemia frequency and associated symptoms. Diabetes Care 1995; 18: 517-22.
139. Mokan M, Mitrakou A, Veneman T, et al. Hypoglycaemia unawareness in IDDM. Diabetes Care 1994; 12: 1397-403.
140. Saberi M, Bohland M, Donovan CM. The locus for hypoglycaemic detection shifts with the rate of fall in glycaemia: the role of portal- superior mesenteric vein glucose sensing. Diabetes 2008; 57: 1380-6.
141. Hevener AL, Bergman RN, Donovan CM. Portal vein afferents are critical for the sympathoadrenal response to hypoglycaemia. Diabetes 2000; 49: 8-12.
142. Donovan C, Halter J, Bergman R. Importance of hepatic glucoreceptors in sympathoadrenal response to hypoglycaemia. Diabetes 1991; 40: 155-8.
143. Biggers DW, Myers SR, Neal D, et al. Role of brain in counterregulation of insulin-induced hypoglycaemia in dogs. Diabetes 1989; 37: 7-16.
144. Frizzell RT, Jones EM, Davis SN, et al. Counterregulation during hypoglycaemia is directed by widespread brain regions. Diabetes 1993; 42: 1253-61.
145. Flynn FW, Grill HJ. Insulin elicits ingestion in decerebrate rats. Science 1983; 221(4606): 188-90.
146. DiRocco RJ, Grill HJ. The forebrain is not essential for sympathoadrenal hyperglycemic response to glucoprivation. Science 1979; 204(4397): 1112-4.
147. Ritter RC, Slusser PG, Stone S. Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science 1981; 213(4506): 451-2.
148. Ritter S, Dinh TT, Zhang Y. Localization of hindbrain glucoreceptive sites controlling food intake and blood glucose. Brain Res 2000; 856(1-2): 37-47.
149. Penicaud L, Pajot MT, Thompson DA. Evidence that receptors controlling growth hormone and hyperglycemic responses to glucoprivation are located in the hindbrain. Endocr Res 1990; 16(4): 461-75.
150. Marty N, Dallaporta M, Foretz M, et al. Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocytedependent glucose sensors. J Clin Invest 2005; 115(12): 3545-53.
151. Borg W, During M, Sherwin R, Borg M, Brines M, Shulman G. Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycaemia. J Clin Invest 1994; 93: 1677-82.
152. Borg W, Sherwin R, During M, Borg M, Shulman G. Local ventromedial hypothalamus glucopaenia triggers counter regulatory hormone release. Diabetes 1995; 44: 180-4.
153. Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycaemia in awake rats. J Clin Invest. 1997; 99: 361-5.
154. Tong Q, Ye C, McCrimmon RJ, et al. Synaptic glutamate release by ventromedial hypothalamic neurones is part of the neurocircuitry that prevents hypoglycaemia. Cell Metab 2007; 5: 383-93.
155. Flanagan DE, Keshavarz T, Evans ML, et al. Role of corticotrophin- releasing hormone in the impairment of counterregulatory responses to hypoglycaemia. Diabetes 2003; 52: 605-13.
156. Evans S, Wilkinson C, Gronbeck P, Bennett J, Taborsky GJ Jr, Figlewicz D. Inactivation of the PVN during hypoglycaemia partially simulates hypoglycaemia-associated autonomic failure. Am J Physiol Regul Integr Comp Physiol 2003; 284: R57-65.
157. Sanders NM, Ritter S. Repeated 2-deoxy-D-glucose-induced glucoprivation attenuates Fos expression and glucoregulatory responses during subsequent glucoprivation. Diabetes 2000; 49: 1865-74.
158. Chan O, Cheng H, Herzog R, et al. Increased GABAergic tone in the ventromedial hypothalamus contributes to suppression of counterregulatory reponses following antecedent hypoglycaemia. Diabetes 2000; 57: 1363-70.
159. Chan O, Zhu W, Ding Y, McCrimmon RJ, Sherwin RS. Blockade of GABA(A) receptors in the ventromedial hypothalamus further stimulates glucagon and sympathoadrenal but not the hypothalamopituitary- adrenal response to hypoglycaemia. Diabetes 2006; 55(4): 1080-7.
160. Song Z, Routh VH. Recurrent hypoglycaemia reduces the glucose sensitivity of glucose-inhibited neurons in the ventromedial hypothalamus nucleus (VMN). Am J Physiol Regul Integr Comp Physiol 2006; 291: R1283-7.
161. Cranston I, Reed LJ, Marsden PK, Amiel SA. Changes in regional brain (18) F-fluorodeoxyglucose uptake at hypoglycaemia in type 1 diabetic men associated with hypoglycaemia unawareness and counter-regulatory failure. Diabetes 2001; 50: 2329-36.
162. Chalmers DT, Lovenberg TW, De Souza EB. Localization of novel corticotrophin-releasing factor receptor 2 (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 1995; 15: 6340-50.
163. Cheng H, Zhou L, Zhu W, et al. Type 1 corticotropin-releasing factor receptors in the ventromedial hypothalamus promote hypoglycaemia- induced hormonal counterregulation. Am J Physiol Endocrinol Metab 2007; 293: E705-12.
164. McCrimmon RJ, Song Z, Cheng H, et al. Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycaemia- induced hormonal counterregulation. J Clin Invest 2006b; 116: 1723-30.
165. During MJ, Leone P, Davis KE, Kerr D, Sherwin RS. Glucose modulates rat substantia nigra GABA release in vivo via ATPsensitive potassium channels. J Clin Invest 1995; 95: 2403-8.
166. Beverly JL, Beverly MF, Meguid MM. Alterations in extracellular GABA in the ventral hypothalamus of rats in response to acute glucoprivation. Am J Physiol 1995; 269: R1174-8.
167. Liu L, Karkanias GB, Morales JC, et al. Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. J Biol Chem 1998; 273: 31160-7.
168. Pocai A, Morgan K, Buettner C, et al. Central leptin acutely reverses diet-induced hepatic insulin resistance. Diabetes 2005; 54: 3182-9.
169. Lam TK, Gutierrez-Juarez R, Pocai A, Rossetti L. Regulation of blood glucose by hypothalamic pyruvate metabolism. Science 2005; 309: 943-7.
170. Yang CS, Lam CK, Chari M, et al. Hypothalamic AMP-activated protein kinase regulates glucose production. Diabetes 2010; 59(10): 2435-43.
171. Kita H, Niijima A, Oomura Y, et al. Pancreatic nerve response induced by hypothalamic stimulation in rats. Brain Res Bull 1980; 5 (Suppl. 4): 163-8.
172. Porte D Jr., Girardier L, Seydoux J, Kanazawa Y, Posternak J. Neural regulation of insulin secretion in the dog. J Clin Invest 1973; 52(1): 210-4.
173. Pavlov IP. Physiology of digestion. Lecture online. (Available at: http://www.nobel.se/medicine/laureates/1904/pavlov-lecture.html) Stockholm: Nobel Foundation 1904.
174. Sarles H, Dani R, Prezelin G, Souville C, Figarella C. Cephalic phase of pancreatic secretion in man. Gut 1968; 9(2): 214-21.
175. Defilippi C, Solomon TE, Valenzuela JE. Pancreatic secretory response to sham feeding in humans. Digestion 1982; 23(4): 217-23.
176. Konturek SJ and Konturek JW. Cephalic phase of pancreatic secretion. Appetite 2000; 34: 197-205.
177. Berthoud HR and Powley TL. Identification of vagal preganglionics that mediate cephalic phase insulin response. Am J Physiol 1990; 258: R523-30.
178. Konturek SJ, Kwiecien N, Obtulowicz W, et al. Cephalic phase of gastric secretion in healthy subjects and duodenal ulcer patients: role of vagal innervation. Gut 1979; 20(10): 875-81.
179. Konturek SJ. Current concepts of neurohormonal control of pancreatic secretion. J Med Sci 1978; 147: 1-11.
180. Alphin RS, Lin TM. Effect of feeding and sham-feeding on pancreatic secretion of the rat. Am J Physiol 1959; 197: 260-2.
181. Trimble ER, Siegel EG, Berthoud HR and Renold AE. Intraportal islet transplantation: functional assessment in conscious unrestrained rats. Endocrinology 1980; 106(3): 791-7.
182. Rorsman P and Renstrom E. Insulin granule dynamics in pancreatic beta cells. Diabetologia 2003; 46: 1029-45.
183. Basu R, Breda E, Oberg AL, et al. Mechanisms of the ageassociated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes 2003; 52: 1738-48.
184. Bergman RN, Phillips NLS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man. Measurement of insulin sensitivity and beta-cell sensitivity from the response to intravenous glucose. J Clin Invest 1981; 68: 1456-67.
185. Basu R, DiCamillo B, Toffolo G, et al. Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol Endocrinol Metab 2003; 284: E55-69.
186. Brunzell JD, Robertson RP, Lerner RL, et al. Relationships between fasting plasma glucose level and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 1976; 42: 222-9.
187. Strubbe JH, Van Wachem P. Insulin secretion by the transplanted neonatal pancreas during food intake in fasted and fed rats. Diabetologia 1981; 20(3): 228-36.
188. Berthoud HR, Trimble ER, Siegel EG, Bereiter DA, Jeanrenaud B. Cephalic-phase insulin secretion in normal and pancreatic islettransplanted rats. Am J Physiol 1980; 38(4): E336-40.
189. Findlay JA, Gill JR, Lever JD, Randle PJ, Spriggs TL. Increased insulin output following stimulation of the vagal supply to the perfused rabbit pancreas. J Anat 1969; 104(Pt 3): 580.
190. Frohman LA, Ezdinli EZ, Javid R. Effect of vagotomy and vagal stimulation on insulin secretion. Diabetes 1967; 16: 443-8.
191. Kaneto A, Kosaka K, Nakao K. Effect of stimulation of the vagus nerve on insulin secretion. Endocrinology 1967; 80: 530-6.
192. Daniel PM, Henderson IR. The effect of vagal stimulation on plasma insulin and glucose levels in the baboon. J Physiol 1967; 192: 317-26.
193. Bloom SR, Edwards AV. Pancreatic endocrine responses to stimulation of the peripheral ends of the vagus nerve in conscious calves. J Physiol (Lond.) 1981; 315: 31-41.
194. Bloom SR, Edwards AV. The release of pancreatic glucagon and inhibition of insulin in response to stimulation of the sympathetic innervations. J Physiol (Lond.) 1975; 252: 157-73.
195. Kaneto, A., Kainuma H and Kosaka K. Effect of splanchnic nerve stimulation on glucagon and insulin output in the dog. Endocrinology 1975; 96: 143-50.
196. Shimazu T, Ishikawa K. Modulation by the hypothalamus of glucagon and insulin secretion in rabbits: studies with electrical and chemical stimulations. Endocrinology 1981; 108: 605-10.
197. Dejong A, Strubbe JH, Steffens AB. Hypothalamic influence on insulin and glucagon release in the rat. Am J Physiol 1977; 233(5): E380-8.
198. Rohner-Jeanrenaud F, Jeanrenaud B. Consequences of ventromedial hypothalamic lesions upon insulin and glucagon secretion by subsequently isolated perfused pancreases in the rat. J Clin Invest 1980; 65(4): 902-10.
199. Rohner F, Dofour AC, Karakash C, Marchand YLe, Ruf KB, Jeanrenaud B. Immediate effect of lesion of the ventromedial hypothalamic area upon glucose induced insulin secretion in anaesthetized rats. Diabetologia 1977; 13 (3): 239-42.
200. Nordback I, Harju E. Immediate effect of vagotomy on pancreatic insulin secretion. Gut 1991; 32: 303-5.
201. Frohman LA, Ezdinli EZ, Javid R. Effect of vagotomy and vagal stimulation on insulin secretion. Diabetes 1967; 16: 443-8.
202. Strubbe JH and Van Wachem P. Insulin secretion by the transplanted neonatal pancreas during food intake in fasted and fed rats. Diabetologia 1981; 20(3): 228-36.
203. Knauf C, Cani P, Perrin C, et al. Brain glucagons-like peptide-1 increases insulin secreation and muscle insulin resistance to favour hepatic glycogen storage. J Clin Invest 2005; 115: 3554-63.
204. Alvarez E, Martínez MD, Roncero I, et al. The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem. J Neurochem 2005; 92: 798-806.
205. Wang R, Cruciani-Guglielmacci C, Migrenne S, Magnan C, Cotero VE, Routh VH. Effects of oleic acid on distinct populations of neurones in the hypothalamic arcuate nucleus are dependent on extracellular glucose levels. J Neurophysiol 2006; 95:1491-8.
206. Cardenas M. Glucokinase: Its regulation and role in liver metabolism. In: Lands RG, Ed. Molecular Biology Intelligence Unit. 1995; p. 210.
207. Colombani AL, Carneiro L, Benani A, et al. Enhanced hypothalamic glucose sensing in obesity: alteration of redox signaling. Diabetes 2009; 58(10): 2189-97.